The European Patent Office (EPO) has published patent application EP2026030145A1, titled "RECOMBINANT VACCINIA VECTORS AND METHODS OF USE THEREOF." This publication, dated March 18, 2026, relates to biotechnological inventions concerning vaccinia vectors, classified under IPC codes C12N 15/86, C07K 14/07, and C12N 7/00. The application is designated for a broad range of European states.

This is a patent publication, not a regulatory rule or guidance. It does not impose direct compliance obligations on regulated entities. However, companies in the biotechnology and pharmaceutical sectors should be aware of this patent application as it pertains to intellectual property within their field. The inventors have not yet been designated, and the application is still in its publication phase.